BioCryst amends 8-K, estimates $6.2 million-$7.5 million in one-time severance costs for discovery shutdown plan
BCRX•Other closure costs still under review
Facility closure costs remain under review, leaving no good-faith estimate yet for lease or contract exits, asset impairments, or related cash charges.
Severance costs estimated at $6.2 million to $7.5 million
Estimated one-time employee termination and severance costs are set at $6.2 million to $7.5 million, including $5.3 million to $6.6 million in cash.
Amended 8-K updates Birmingham facility shutdown disclosures
BioCryst filed an amended Form 8-K to update disclosures on its plan to shut its Birmingham discovery facility, announced June 29, 2026.
